findmyKOL
Clinical trialNCT04268303CompletedPhase 3Interventional

Dexmedetomidine in the Treatment of Agitation Associated With Schizophrenia

SponsorBioXcel Therapeutics IncEnrollment380AgitationSchizo Affective DisorderSchizoaffective DisorderSchizophreniaSchizophreniform Disorders
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

15 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Bioxcel Clinical Research Site

    Little Rock, Arkansas, United States

  • Bioxcel Clinical Research Site

    Cerritos, California, United States

  • Bioxcel Clinical Research Site

    Culver City, California, United States

  • Bioxcel Clinical Research Site

    Long Beach, California, United States

  • Bioxcel Clinical Research Site

    Orange, California, United States

  • Bioxcel Clinical Research Site

    Miami Lakes, Florida, United States

  • Bioxcel Clinical Research Site

    Chicago, Illinois, United States

  • Bioxcel Clinical Research Site

    Gaithersburg, Maryland, United States

  • Bioxcel Clinical Research Site

    Las Vegas, Nevada, United States

  • Bioxcel Clinical Research Site

    Berlin, New Jersey, United States

  • Bioxcel Clinical Research Site

    Marlton, New Jersey, United States

  • Bioxcel Clinical Research Site

    Charleston, South Carolina, United States

  • Bioxcel Clinical Research Site

    Austin, Texas, United States

  • Bioxcel Clinical Research Site

    DeSoto, Texas, United States

  • Bioxcel Clinical Research Site

    Richardson, Texas, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
24 Jan 2020
Primary completion
6 May 2020
Completion
6 May 2020
Last update posted
4 Jun 2026
Registered enrollment
380
Registry id
NCT04268303

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.